NAV

HIV Integrase Inhibitor

This drug entry is astuband has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
HIV Integrase Inhibitor
DrugBank Accession Number
DB16114
Background

HIV Integrase Inhibitor is under investigation in clinical trial NCT00397566 (A Multiple Ascending Dose Study of BMS-707035 in HIV-1 Infected Subjects).

Type
Small Molecule
Groups
Investigational
Structure
 3D
Similar Structures
Weight
Average: 410.42
Monoisotopic: 410.106019065
Chemical Formula
C17H19FN4O5S
Synonyms
  • BMS 707035
External IDs
  • BMS 707035
  • bms - 707035

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
7PR4P7YOKT
CAS number
729607-74-3
InChI Key
VNIWZCGZPBJWBI-UHFFFAOYSA-N
InChI
InChI=1S/C17H19FN4O5S/c1-21-16(25)14(23)13(15(24)19-10-11-4-6-12(18)7-5-11)20-17(21)22-8-2-3-9-28(22,26)27/h4-7,23H,2-3,8-10H2,1H3,(H,19,24)
IUPAC Name
2-(1,1-dioxo-1lambda6,2-thiazinan-2-yl)-N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide
SMILES
CN1C(=O)C(O)=C(N=C1N1CCCCS1(=O)=O)C(=O)NCC1=CC=C(F)C=C1

References

一般引用
Not Available
ChemSpider
10639881
ChEMBL
CHEMBL486226
ZINC
ZINC000003842433

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
2 Withdrawn Treatment Human Immunodeficiency Virus (HIV) Infections 1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
Property Value 源
Water Solubility 0.0413 mg/mL ALOGPS
logP 1.13 ALOGPS
logP 0.31 Chemaxon
logS -4 ALOGPS
pKa (Strongest Acidic) 7.03 Chemaxon
pKa (Strongest Basic) -2.2 Chemaxon
Physiological Charge -1 Chemaxon
Hydrogen Acceptor Count 6 Chemaxon
Hydrogen Donor Count 2 Chemaxon
Polar Surface Area 119.38 Å2 Chemaxon
Rotatable Bond Count 4 Chemaxon
Refractivity 99.47 m3·mol-1 Chemaxon
Polarizability 38.55 Å3 Chemaxon
Number of Rings 3 Chemaxon
Bioavailability 1 Chemaxon
Rule of Five Yes Chemaxon
Ghose Filter Yes Chemaxon
Veber's Rule No Chemaxon
医学博士DR-like Rule No Chemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at December 15, 2020 18:12 / Updated at December 20, 2020 03:37